Capitol Health
VC Fund
Docklands, Australia
Capitol Health is a VC fund in Docklands focused on Software and Analytics. Capitol Health Limited (ASX: CAJ) is an Australian public company providing medical diagnostic imaging services.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Capitol Health invests in
Stages Capitol Health invests in
Countries Capitol Health invests in
Investment Focus
Industry
- Software 1 (33%)
- Analytics 1 (33%)
- Health Care 1 (33%)
- Medical Device 1 (33%)
- Clinical Trials 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enlitic
|
Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions ofclinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based in San Francisco and serves customers around the world. | $25M / Series B / Nov 14, 2019 | |
|
Enlitic
|
Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions ofclinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based in San Francisco and serves customers around the world. | $15M / Series B / Apr 04, 2019 | |
|
Enlitic
|
Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions ofclinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based in San Francisco and serves customers around the world. | $10M / Series B / Oct 27, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Capitol Health invest in?
Capitol Health invests primarily in Software, Analytics and Health Care startups, most often at Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Capitol Health last invest?
The most recent investment recorded for Capitol Health closed in Nov 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
